Kajal B Larson Selected Research

Kajal B Larson Research Topics

5	Infections 01/2019 - 01/2013
3	Urinary Tract Infections (Urinary Tract Infection) 01/2020 - 11/2018
2	Critical Illness (Critically Ill) 04/2021 - 01/2020
2	Intraabdominal Infections 01/2020 - 01/2019
2	Body Weight (Weight, Body) 01/2019 - 01/2017
1	Bacterial Infections (Bacterial Infection) 04/2021
1	AIDS-Related Complex (ARC) 04/2021
1	Pneumonia (Pneumonitis) 01/2020
1	Ventilator-Associated Pneumonia 01/2020
1	Bacterial Pneumonia 01/2020
1	Cystic Fibrosis (Mucoviscidosis) 01/2020
1	Gram-Negative Bacterial Infections 01/2019
1	Necrotizing Pneumonia 01/2017
1	Clostridium Infections 01/2017
1	Ureaplasma Infections (Ureaplasma Infection) 03/2014

5	tazobactam drug combination ceftolozaneIBA 04/2021 - 11/2018
3	Tazobactam FDA LinkGeneric 04/2021 - 01/2019
3	ceftolozaneIBA 04/2021 - 01/2019
2	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2020 - 01/2019
2	Azithromycin (Zithromax)FDA LinkGeneric 06/2015 - 03/2014
1	CreatinineIBA 04/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2018
1	Bacterial Proteins (Bacterial Protein)IBA 01/2017
1	tedizolid phosphateIBA 01/2017
1	Linezolid (Zyvox)FDA Link 01/2017
1	Vancomycin FDA LinkGeneric 01/2017
1	CB-183,315IBA 01/2017
1	Oxazolidinones (2 Oxazolidone)IBA 01/2017
1	MacrolidesIBA 06/2015
1	HIV IntegraseIBA 01/2013
1	Raltegravir Potassium FDA Link 01/2013
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 01/2013

1	Mechanical Ventilators (Ventilator) 01/2020
1	Intravenous Infusions 01/2019
1	Aftercare (After-Treatment) 01/2017